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Abstract
Benzodiazepines are detected in a significant number of drug facilitated sexual assaults (DFSA). Whilst blood and urine from
the victim are routinely analysed, due to the delay in reporting DFSA cases and the short half lives of most of these drugs in
blood and urine, drug detection in such samples is problematic. Consideration of the drinks involved and analysis for drugs
may start to address this. Here we have reconstructed the ‘spiking’ of three benzodiazepines (diazepam, flunitrazepam and
temazepam) into five drinks, an alcopop (flavoured alcoholic drink), a beer, a white wine, a spirit, and a fruit based non-
alcoholic drink (J2O) chosen as representative of those drinks commonly used by women in 16–24 year old age group.
Using a validated GC-MS method for the simultaneous detection of these drugs in the drinks we have studied the storage
stability of the benzodiazepines under two different storage conditions, uncontrolled room temperature and refrigerator
(4uC) over a 25 day period. All drugs could be detected in all beverages over this time period. Diazepam was found to be
stable in all of the beverages, except the J2O, under both storage conditions. Flunitrazepam and temazepam were found
not to be stable but were detectable (97% loss of temazepam and 39% loss of flunitrazepam from J2O). The
recommendations from this study are that there should be a policy change and that drinks thought to be involved in DFSA
cases should be collected and analysed wherever possible to support other evidence types.
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Introduction
Drug-facilitated sexual assault (DFSA) is sexual activity (i)
without the consent or (ii) the invalid consent of a participant when
the victim is under the influence of drugs, noxious substances or
chemical agents [1]. The use of sedatives for DFSA is not a new
concept, in fact related legislation has existed in the United
Kingdom since the Offences Against the Person Act, 1861
followed by the Sexual Offences Act, 1956 and 2003 [2]. DFSA
has, in recent years, been classified as either ‘pro-active’ or
‘opportunistic’. Pro-active DFSA relates to the covert administra-
tion of a substance to the victim where purpose of the perpetrator
is sexual assault. Opportunistic DFSA relates to cases where the
victim has been rendered nearly or fully unconscious by their own
actions prior to the sexual assault [1–3]. Previous literature
indicates an increase in the number of claims of DFSA [3–4],
which could be due to the advent of drugs which are easier to
administer without the victim’s knowledge and better media
coverage leading to increase in awareness [5–6].
Benzodiazepines are used by those who wish to commit DFSA
because drugs such as diazepam, temazepam and flunitrazepam
have a sedative effect and ability to cause amnesia [7–9]. These
drugs are readily absorbed in the gastro-intestinal tract when taken
orally with food which only delays the rate, but not the extent of
absorption [10]. The absorption leads to altered mental state,
drowsiness, confusion, slurred speech and lack of co-ordination
[8].
Benzodiazepines have also been found to be present in a
significant number of suspected DFSA cases [2,10–15]. It should
be noted that some of these positive samples may be due to
prescribed or voluntary ingestion [2–3,10] but the difference is not
reported in the papers.
The three benzodiazepines were chosen because flunitrazepam
is widely considered as date rape drug, diazepam is the most
frequently encountered benzodiazepines in DFSA cases [11] and
temazepam is a metabolite of diazepam and is also frequently
encountered in casework [2,16]. With regard to the link of
flunitrazepam in DFSA cases, Roche Products Limited, manufac-
turer of Rohypnol (active ingredient flunitrazepam), has reformu-
lated the drug by making its dissolution more difficult and
generating a bright blue colour [17]. However, other preparations
that contain flunitrazepam as their active substance (FlunipamR:
1 mg flunitrazepam, Alpharma Inc, Norway; HypnodormR: 1 mg
flunitrazepam, Alphapharm Pty Ltd, Australia) are still available in
the market.
Blood and urine are routinely collected for toxicological
analysis. Due to the short detection window of benzodiazepines
in blood (48 h) and urine (96 h), with some exceptions (12 h for
midazolam, 7 days for diazepam) [8], alternative specimens such
as hair may be preferred. Benzodiazepines are detectable in hair
for months and years depending on the length of the sample.
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e89031
Research has been encouraged into such non-routine specimens as
the time frame between the assault taking place and the reporting
is often prolonged [11] negating the use of blood and urine
samples [6,15].
The testing of drink samples may also be of use in clarifying the
events relating to alleged sexual assault where there has been a
delay in reporting or collection of routine toxicology samples [18].
Empty glasses, bottles and vomit have all been submitted to the
Forensic Science Services (FSS) in the UK for analysis in cases of
alleged DFSA [2]. The conditions and duration of handling and
storage of specimens for analysis have the potential to alter drug
concentrations considerably. As initial concentrations of drug are
generally of interest toxicologically, knowledge of the stability of
these drugs in different matrices, and therefore the potential for
variance between detected concentration and initial concentration,
is important [19].
Benzodiazepines have been evaluated for stability in relation to
storage temperatures for pre-hospital purposes - this included
injectable solutions in clear glass syringes. In this sterile setting it
was found that both diazepam and lorazepam showed significant
decreases in concentration at ambient temperatures and at 37uC,
and that refrigeration did not completely halt the process [20].
The stability of benzodiazepines under long term storage
conditions in biological matrices has been researched with
material relating to saliva, blood and urine samples. For whole
blood samples storage at below 220uC has been recommended to
minimise loss of concentration [21]. Similarly, another study
reported that storage at ambient temperatures of bromazepam in
plasma lead to degradation [22] and blood and plasma samples
spiked with thirteen benzodiazepines and metabolites stored at
4uC showed at least 60% loss of analytes compared to original
levels after 240 days [23]. This reflects the general recommenda-
tion that clinical or forensic specimens should be refrigerated, or
preferably stored at 220uC or lower, to avoid degradation [19].
It is clear that there are a number of potential issues relating to
the storage of benzodiazepine containing samples – the stability of
the drugs themselves and the potential interactions with the matrix
that they are contained in. A lack of research relating to the
stability of benzodiazepines over time in different drinks and
storage conditions has been identified.
A GC-MS method has been validated and applied to common
beverages spiked with benzodiazepines to simulate casework
samples stored under different controlled conditions at increasing
time intervals. This research will inform law enforcement officers
and analysts about the collection, storage conditions, duration of
storage, analytical conditions and interpretation of data when
drinks alleged to have been used for DFSA are analysed.
Experimental
Materials and Chemicals
All chemicals used were analytical reagent grade or better.
Chloroform, ethyl acetate, isopropanol and methanol were
purchased from Fisher Chemicals; eicosane was purchased from
Acros Organics; diazepam, diazepam-d5, flunitrazepam and
temazepam were purchased from Sigma Chemical Company;
bis(trimethyl)trifluoroacetamide (BSTFA) containing 1% tri-
methylchlorosilane (TMCS) derivatising agent was purchased
from Supelco Analytical.
The beverages used were Bacardi Breezer, an alcopop, orange
flavour, 4% by volume, Becks Beer, 5% by volume, Hardy’s
Classic Selection Chardonnay 2010, 12.5% by volume, J2O apple
and mango, Chekov Imperial Vodka, 37.5% by volume, and were
all purchased from local supermarket stores in Cambridge, UK
during the period Oct 10–July 2011. The five drinks tested in this
research were selected to represent common drink types consumed
by women in the 16–24 years age group – a group at considerable
risk of being the victim of DFSA.
Standard Solutions
A mixed drug standard of diazepam, flunitrazepam and
temazepam was prepared with each at a concentration of
100 mg/mL in methanol. When appropriate, the internal standard
(IS), diazepam-d5, was added to give a final IS concentration of
25 mg/mL.
Derivatisation of Samples
To derivatise the drugs prior to analysis owing to thermal
instability of temazepam, each solution was evaporated to dryness
using a miVac sample concentrator (Genevac Ltd., UK) at 30uC.
Derivatisation was performed by addition of BSTFA: TCMS
(40 mL, 99:1%) and IS eicosane (20 mL, 100 mg/mL) in ethyl
acetate and heating to 70uC for 15 minutes. The samples were
analysed immediately after derivatisation.
Instrumentation and Compound Identification
A Shimadzu QP 2010 GC-MS fitted with a ZB1 column
(0.25 mm layer thickness, 0.25 mm i.d.) was utilised with split
injection (14:1) at 250uC. The injection volume was 1 mL. The
column flow rate (He carrier gas) was 1.2 mL/min. The oven
Table 1. Compound identification parameters (n = 27).
Spiked drinks Diazepam Flunitrazepam Silylated temazepam
RTa 6 RSDb RIc RTa 6 RSDb RIc RTa 6 RSDb RIc
Pure drug 9.3060.013 1.001 10.2960.030 1.104 10.2360.061 1.10
Bacardi Breezer 9.3260.115 1.002 10.2860.051 1.110 10.2260.056 1.10
Becks Beer 9.3260.041 1.001 10.2860.050 1.110 10.2260.054 1.10
Hardys Chardonnay 9.3260.040 1.001 10.2860.055 1.110 10.2160.055 1.10
Chekov Imperial Vodka 9.3260.042 1.001 10.2860.048 1.110 10.2260.046 1.10
J2O Apple & Mango 9.3260.036 1.001 10.2860.042 1.110 10.2160.050 1.10
aRetention time/min.
bRelative standard deviation/%.
cretention index = RT of analyte/RT of Internal standard.
doi:10.1371/journal.pone.0089031.t001
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temperature programme was 150uC (2 min), then increasing at a
rate of 20uC/min to 280uC and held at 280uC for 5 minutes. The
quadrupole mass analyser was operated in electron impact (EI)
mode. The ion source temperature was 230uC, interface
temperature was 300uC and solvent delay time was 3 minutes.
Samples were analysed in full scan and extracted ion modes which
were used for data analysis. Ethyl acetate blanks were run between
all samples, controls and standards to prevent carry over.
Compounds were identified on the basis of retention index
(compared to diazepam-d5) and mass spectrum. An unspiked
sample of each of the beverages was prepared using the extraction
and derivatisation method and was analysed in an identical
manner to all other samples. This was to demonstrate that there
were no drugs or compounds giving identical data in the reagents
and drink matrices. In addition, linearity on the drug response was
established using pure drug standards as well as spiked beverages.
Table 2. Mass spectrometry data for diazepam, flunitrazepam and silylated temazepam as pure compounds and after extraction
from beer as exemplar data.
Drug Ion (m/z) % intensity of pure compounds % intensity after extraction from spiked beer
Diazepam 285 42 42
284 74 71
283 97 94
257 46 43
256 100 100
221 33 36
Flunitrazepam 313 67 69
312 100 100
286 97 90
266 61 59
238 43 40
183 20 20
Silylated temazepam 372 19 21
345 36 39
344 25 26
343 100 100
283 31 37
257 36 44
221 6 7
doi:10.1371/journal.pone.0089031.t002
Table 3. Calibration and mass spectra interpretation for diazepam, silylated temazepam and flunitrazepam standards.
Drug
Regression
equation R2 value LODa/ng LOQb/ng
Major
ions/m/z Interpretation % abundance
Diazepam Y= 27.76 +0.27 0.978 0.571 0.643 256 [M-CO]+ or
[M-(H+HCN)]+
100
283 [M-H]+ 97
221 [M-(CO+Cl)]+ or
[M-(H+HCN+Cl)]+
33
Flunitrazepam Y= 12.026–0.797 0.983 0.714 1.286 312 [M-H]+ 100
286 [M-HCN]+ 97
266 [M-(H+NO2)]+ or
[M-(CO+F)]+ or
[M-(H+HCN+F)]+
61
Silylated
temazepam
Y= 35.76 +0.064 0.977 0.500 0.714 343 [M-(H+CO)]+ or
[M-(2H+HCN)]+
100
283 [M-(OSi(CH3)3+H)]+ 31
257 [M-NCHOSi(CH3)3]
+ 36
aLimit of detection on column, IUPAC method.
bLimit of quantification on column, IUPAC method.
doi:10.1371/journal.pone.0089031.t003
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Sample Preparation: Drink Spiking and Storage
The Bacardi Breezer, Becks Beer, Hardys Chardonnay, Chekov
Imperial Vodka and J2O (20 mL) were each spiked with
individual drug solutions to give a final concentration of 10 mg/
mL (diazepam and temazepam) and 20 mg/mL flunitrazepam.
The difference in concentration is owing to the instrumental
response. The beer and the Bacardi Breezer were degassed using
an ultrasonic bath prior to addition of the drugs. Spiked beverages
were divided into two aliquots (10 mL each) and stored at room
temperature, which fluctuated diurnally, and in the refrigerator at
4uC, until liquid liquid extraction (LLE) and GC-MS analysis was
carried out.
Extraction of Benzodiazepines from Spiked Drinks
The IS (diazepam-d5) was added to individual drinks (0.5 mL
aliquots), to give a final concentration of 25 mg/mL, immediately
prior to extraction. LLE was performed using chloroform:
isopropanol (1:1 v/v, 100 mL63) directly after spiking and on
unspiked beverages [18]. Once extracted, the organic phase
(bottom) was collected and subjected to analysis.
Method Validation and Quantitation
Each of the beverages (10 mL) was spiked using individual drug
solutions of 1 mg/mL diazepam and temazepam; and 2 mg/mL
flunitrazepam to give the concentrations range of 2.5–50 mg/mL
for diazepam and temazepam; 5–100 mg/mL for flunitrazepam.
Analytes were extracted, derivatised and analysed as described
above.
Simulated Case
White wine samples were spiked with individual drugs to give
final concentrations of 0.833 mg/mL each of diazepam and
temazepam to simulate casework samples. This concentration was
selected within the linear range. Each sample was analysed using
the extraction and derivatisation method described above. Once
the analysis was complete the identity of the drugs and the
quantities detected were compared to those expected.
Table 4. Method validation and Kruskall-Wallis U test results from spiked beverages.
Spiked beverages a,bLOD/ng b,cLOQ/ng dRecovery % 6 eSD
fIs the difference significant at 95% CI?
RT storage 4uC storage
Diazepam Bacardi Breezer 0.25 0.714 8967.9 No No
Beer 0.571 1.43 8468.4 No No
Vodka 0.286 1 9962.9 No No
White wine 0.071 0.156 8665.4 No No
J2O 0.143 0.5 8666.5 Yes No
Flunitrazepam Bacardi Breezer 0.528 1.71 77615 No No
Beer 1.07 1.5 101620 No Yes
Vodka 0.356 1.14 9764.1 No Yes
White wine 0.082 0.273 5665.3 Yes Yes
J2O 0.643 2.11 8566.5 Yes Yes
Silylated
temazepam
Bacardi Breezer 0.143 0.431 8462.5 Yes Yes
Beer 0.071 0.357 97613 Yes No
Vodka 0.143 0.357 9066.7 Yes Yes
White wine 0.071 0.143 8164.1 Yes Yes
J2O 0.214 0.693 105610 Yes Yes
aLimit of detection,
bIUPAC method,
climit of quantification,
dn = 3,
estandard deviation,
fKruskall-Wallis U test at 95% confidence interval.
doi:10.1371/journal.pone.0089031.t004
Figure 1. Peak height ratio (PHR) of diazepam: diazepam -d5
(n=3).
doi:10.1371/journal.pone.0089031.g001
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Figure 2. Peak height ratio (PHR) of flunitrazepam: diazepam -d5 (n=3).
doi:10.1371/journal.pone.0089031.g002
Figure 3. Peak height ratio (PHR) of silylated temazepam: diazepam -d5 (n=3).
doi:10.1371/journal.pone.0089031.g003
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Results and Discussion
Compound Identification
The GC-MS method reported here was followed after
derivatisation that allowed identification of temazepam, whereas
diazepam and flunitrazepam could have been analysed without
derivatisation. Sample injection without derivatisation of temaz-
epam resulted in its decomposition. Temazepam is known to be
thermally labile [24]. The data obtained for the standard drugs
and drugs extracted from the drinks were identical with respect to
retention index (Table 1) and mass spectrometry (Table 2). This
allowed identification and quantification of the drugs. Solvent
blanks and sample matrices were analysed to ensure there was no
carryover between sample injections. Results from the matrix
blank and negative controls demonstrated the absence of drugs in
these samples. This proves that the chromatographic peaks and
mass spectroscopic data could only have come from the drugs
themselves and that there was nothing in any of the drinks tested
which gave identical data indicating selectivity of the method.
Method Validation Results
Extracted ions (diazepam m/z=256; diazepam-d5 m/z= 261;
flunitrazepam m/z= 343 and temazepam m/z= 312) were utilised
to construct calibration graphs for the pure drugs – the regression
equations and r2 values are provided in Table 3. A linear detector
response range was established for each drug in the ranges 0.025–
0.25 mg/mL for diazepam and temazepam; and 0.05–1 mg/mL
for flunitrazepam. The limit of detection (LOD) and limit of
quantification (LOQ) were calculated using IUPAC (International
Union of Pure and Applied Chemistry), 2009 [25] and are also
given in Table 3. LOD ranged from 0.50–0.71 ng and LOQ
ranged from 0.64–1.29 ng on column.
Calibration curves were also constructed for the drugs extracted
from the drinks in a fashion analogous to those for pure
compounds. The LOD and LOQ data are given in Table 4.
The recovery of each of the drugs from each of the drinks was
measured (Table 4) with values of diazepam 84–99%, flunitraze-
pam 56–101% and temazepam 81–105% depending upon the
drink (Table 4). Recovery was least good from the white wine and
flunitrazepam was particularly poor from the white wine (56%)
and the Bacardi Breezer (77%). The reasons for this are more
complicated than recovery merely being a function of the pH
values of these drinks which lay in the range between pH 3.2 to
pH 3.4 and the pKa value of flunitrazepam (pKa= 1.8) otherwise
temazepam (pKa= 1.6) should have been extracted equally poorly.
The factors affecting recovery were not investigated further.
Recovery of all drugs from both the beer and the vodka were good
with mean values of 84–101%.
Stability of the Drugs under Different Storage Conditions
All of the spiked beverages stored at room temperature and at
4uC were subjected to LLE at the given time intervals. The results
show that the drugs were detected under both storage conditions
throughout the study period, although some drugs were more
stable than others. Exemplar results for analytes extracted from
drinks stored at room temperature for example, diazepam
(Figure 1) flunitrazepam (Figure 2) and silylated temazepam
(Figure 3) show a clear difference between the stability of the
individual analytes in different beverages. In order to determine
whether or not there is a significant difference in these results the
Kruskal-Wallis U test was used. The chi-squared (x2) statistic and
p value were calculated and compared with the critical x2 value at
95% confidence interval for 3 degrees of freedom and the
summary of results are given in Table 4.
The Kruskal-Wallis U test showed that for diazepam there was
no significant difference between the results obtained after storage
at room temperature and at 4uC in any beverage except J2O
(Figure 1, Table 4). In J2O, at room temperature, there was
evidence of diazepam degradation. The cause of this was not
investigated further. For flunitrazepam significant differences were
observed after storage under both conditions in wine and J2O
(Figure 2, Table 4). The instability is not linked to the sample pH
and alcoholic content of the beverage because both of them have
(i) same pH of 3.2 (ii) the wine is 12.5% v/v ethanol, the J2O is
alcohol free. There was significant loss of temazepam in all the
beverages analysed after storage in both conditions (Figure 3,
Table 4) except beer at 4uC. In general the stability of
benzodiazepines depended on the type of beverage in which they
were dissolved. J2O in particular showed significant differences for
all the analytes under both storage conditions.
Factors which might potentially impact upon the stability of
benzodiazepines in a beverage are pH, alcohol concentration,
extraction and analysis. Our results do not show any pattern
related to them in the Kruskal-Wallis U significance tests.
Simulated Case
Blind trial samples were extracted, derivatised and analysed
following the method developed and presented in this paper. The
drugs were each correctly identified. The concentrations of the
drugs in the drinks lay between 95–100% of the true values.
Against a true value of 0.083 mg/mL, the concentration of
diazepam was detected at 0.079 mg/mL (95% recovery),
0.083 mg/mL (100% recovery) for temazepam from white wine.
Conclusion
A GC-MS method for the simultaneous extraction and
detection of three commonly detected benzodiazepines namely
diazepam, flunitrazepam and temazepam has been adapted,
validated and applied to beverages spiked with benzodiazepines
implicated in DFSA cases. The advantage of this method is that it
covers thermally stable and labile benzodiazepines. Thermal
lability can be overcome through derivatisation using BSTFA-
TCMS. The method presented here is selective, specific, yields
good recovery of the analytes, provides linear calibration data and
achieves lower LOD and LOQ than previously described.
The study of drugs in foodstuff and beverages is an important
aspect in some forensic cases (HMA-v-Webster, 2012; R-v-Erin,
2012; R-v-Wilson) [26–28]. In these examples drugs were
administered via foodstuffs and drinks and in the second of these
cases, knowledge of the effect of prolonged dissolution of the drug
would have been important for data interpretation. The same is
true for benzodiazepines in drinks. Whilst benzodiazepines do not
occur in beverages, it is important to know concentration in the
drink, in some legislative systems, if interpretation of the effect that
the drug would have is to be made.
There is a gap in the literature with respect to the stability of
benzodiazepines in beverages over time and under different
storage conditions. This study proves that diazepam, flunitraze-
pam and temazepam can be detected in Bacardi Breezer, beer,
white wine, vodka and J2O for a 25 day period after storage at
both room temperature and at 4uC. However, issues of stability
exist for benzodiazepines in beverages, particularly for flunitraze-
pam and temazepam. This study demonstrates that such samples
should be analysed as soon as possible after seizure regardless of
how they are stored.
Additionally, due to the decomposition of the benzodiazepines it
is not possible to determine the original concentration of the drug
Stability of Benzodiazepines in Spiked Drinks
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in the drink at the time of alleged administration. This has
consequences in the forensic science context in that it may not be
possible to determine whether a drug in a drink would have had an
effect – especially when the drug concentration at the time of
analysis is low. Of course, the presence of a drug in a drink should
raise suspicion about the events that have led to its presence and
association with the case under investigation. These spiked drinks
will constitute additional evidence in DFSA casework.
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